openPR Logo
Press release

Pancreatic Cancer Therapeutics Market worth $9.09 billion by 2030, growing at a CAGR of 9.95% - Exclusive Report by 360iResearch

03-04-2024 10:29 AM CET | Health & Medicine

Press release from: 360iResearch

Pancreatic Cancer Therapeutics Market | 360iResearch

Pancreatic Cancer Therapeutics Market | 360iResearch

The "Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Pancreatic Cancer Therapeutics Market to grow from USD 4.67 billion in 2023 to USD 9.09 billion by 2030, at a CAGR of 9.95%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/pancreatic-cancer-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Pancreatic cancer therapeutics encompass a variety of treatment modalities used to manage and combat pancreatic cancer, known for its aggressive nature and challenging prognosis. The therapeutic landscape for this malignancy includes surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and supportive care measures that aim to relieve symptoms and improve the quality of life for patients. The need for pancreatic cancer therapeutics is driven by the increasing prevalence of the disease, attributed to factors such as aging populations, lifestyle-related risk factors, and genetic predispositions. Additionally, supportive government policies to expand access to affordable pancreatic cancer treatment have extended the scope and reach of the therapeutic options for patients. However, the complex reimbursement landscape and the inability of clinical trials to provide beneficial and credible results pose concerns about the accuracy and efficacy of the therapies. Moreover, there has been some significant progress in understanding the biology of the disease, resulting in the development of targeted therapeutics and personalized medicine approaches. These treatments are designed to interfere with specific pathways or mechanisms that promote the growth and spread of pancreatic cancer cells.

The Americas region, particularly the United States and Canada, is characterized by the presence of a robust clinical pipeline, high healthcare expenditure, and several major pharmaceutical companies. Food and Drug Administration (FDA) has approved designations such as Fast Track, Breakthrough Therapy, and Orphan Drug to several pancreatic cancer drugs, which accelerates the regulatory approval process. European nations such as Germany, France, and the United Kingdom are characterized by the presence of heightened healthcare spending, advanced healthcare facilities, and favorable reimbursement policies. The European Medicines Agency (EMA) plays a pivotal role in endorsing new therapeutic options, positively impacting market growth. Strong research collaborations between private and public entities drive innovation in cancer therapeutic research. In APAC countries such as China, Japan, India, and South Korea, there is a growing patient population and increasing awareness regarding cancer diseases, driving the need for therapeutic options. The increase in local generic drug production in countries such as India contributes to regional market dynamics.

Market Segmentation & Coverage:

This research report categorizes the Pancreatic Cancer Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Endocrine Pancreatic Cancer and Exocrine Pancreatic Cancer. The Exocrine Pancreatic Cancer commanded largest market share of 71.51% in 2023, followed by Endocrine Pancreatic Cancer.

Based on Product, market is studied across Chemotherapy, Gene Therapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy. The Chemotherapy commanded largest market share of 34.04% in 2023, followed by Radiation Therapy.

Based on End-Use, market is studied across Cancer Centers/Clinics, Hospitals, and Research Institutes. The Hospitals commanded largest market share of 42.20% in 2023, followed by Research Institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 43.39% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/pancreatic-cancer-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Pancreatic Cancer Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Pancreatic Cancer Therapeutics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Pancreatic Cancer Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Amgen Inc., Ascentage Pharma Group, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, Carrick Therapeutics Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Faeth Therapeutics, Inc., FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., GenesisCare, GlaxoSmithKline PLC, Hetero Healthcare Limited, ImmunityBio, Inc., Innovent Biologics Inc., Johnson & Johnson Services, Inc., Lupin Limited, Merck & Co., Inc., Mitsubishi Heavy Industries, Ltd., NGM Biopharmaceuticals, Inc., NovalGen, Novartis AG, PanTher Therapeutics, Inc., Pfizer, Inc., RenovoRx, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zentalis Pharmaceuticals, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Pancreatic Cancer Therapeutics Market, by Type
7. Pancreatic Cancer Therapeutics Market, by Product
8. Pancreatic Cancer Therapeutics Market, by End-Use
9. Americas Pancreatic Cancer Therapeutics Market
10. Asia-Pacific Pancreatic Cancer Therapeutics Market
11. Europe, Middle East & Africa Pancreatic Cancer Therapeutics Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Pancreatic Cancer Therapeutics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Pancreatic Cancer Therapeutics Market?
3. What is the competitive strategic window for opportunities in the Pancreatic Cancer Therapeutics Market?
4. What are the technology trends and regulatory frameworks in the Pancreatic Cancer Therapeutics Market?
5. What is the market share of the leading vendors in the Pancreatic Cancer Therapeutics Market?
6. What modes and strategic moves are considered suitable for entering the Pancreatic Cancer Therapeutics Market?

Read More @ https://www.360iresearch.com/library/intelligence/pancreatic-cancer-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pancreatic Cancer Therapeutics Market worth $9.09 billion by 2030, growing at a CAGR of 9.95% - Exclusive Report by 360iResearch here

News-ID: 3409460 • Views:

More Releases from 360iResearch

Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - Exclusive Report by 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample The utilization of satellite IoT is significantly growing across various regions,
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8.99% - Exclusive Report by 360iResearch
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8 …
The "Laboratory Chemicals Market by Type (Biochemistry, Carbohydrate Analysis, Cell/Tissue Culture), Application (Academia/Educational, Government, Healthcare & Pharmaceutical) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Laboratory Chemicals Market to grow from USD 22.41 billion in 2023 to USD 40.97 billion by 2030, at a CAGR of 8.99%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/laboratory-chemicals?utm_source=openpr&utm_medium=referral&utm_campaign=sample Laboratory chemicals include acids, solvents, reagents, and analytical standards for testing and experiments. Laboratory
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - Exclusive Report by 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample The utilization of satellite IoT is significantly growing across various regions,
Disposable Surgical Gloves Market worth $12.56 billion by 2030, growing at a CAGR of 9.84% - Exclusive Report by 360iResearch
Disposable Surgical Gloves Market worth $12.56 billion by 2030, growing at a CAG …
The "Disposable Surgical Gloves Market by Product (Natural Rubber Gloves, Nitrile Disposable Gloves, Vinyl Disposable Gloves), Form (Powdered Gloves, Powdered-Free Gloves), Distribution Channel, End-Users - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Disposable Surgical Gloves Market to grow from USD 6.51 billion in 2023 to USD 12.56 billion by 2030, at a CAGR of 9.84%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/disposable-surgical-gloves?utm_source=openpr&utm_medium=referral&utm_campaign=sample Disposable surgical gloves are used by

All 5 Releases


More Releases for Pancreatic

Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025 Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025 Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025 Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Pancreatic Market to Insight By 2025: Top Key Vendors Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023. Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,